Skip to calculator

Free Clinical Tool · PMOS Guidelines 2023 · Mifflin–St Jeor · India-Calibrated

PMOS Nutrition &
Calorie Calculator.

Evidence-based TDEE, insulin-resistance macro targets, and Indian low-GI meal suggestions — built on international guidelines for Polyendocrine Metabolic Ovarian Syndrome (formerly PCOS).

✓ PMOS (formerly PCOS) · Int'l Guidelines 2023
✓ Mifflin–St Jeor REE · PAL Bands
✓ Low-GI / IR-Optimised Macros · 3 Templates
✓ Indian Low-GI Meal Suggestions

Enter Your Details

TDEE · Low-GI macros · Indian meal plan · PMOS correction

For adult women with confirmed or suspected PMOS (Polyendocrine Metabolic Ovarian Syndrome, formerly PCOS). Educational tool only — not a substitute for dietitian or gynaecologist advice. Women with disordered eating, pregnancy, or severe comorbidities should seek direct clinical support.
Age, Height & Weight * REE computed via Mifflin–St Jeor. BMI auto-calculated to set evidence-aligned deficit targets (Int'l PMOS Guidelines 2023).
Physical Activity Level * PAL multiplier on REE → TDEE. PMOS guidelines recommend ≥150 min/week moderate + 2 days resistance. ≥250 min/week for significant weight loss.
Nutrition Goal * Int'l PMOS Guidelines (2023): 5–10% weight loss over ~6 months produces clinically meaningful improvement in metabolic, reproductive and psychological outcomes.
Insulin Resistance / Glucose Status * Sets default macro template. Low-GI high-fibre pattern improves insulin sensitivity, menstrual regularity and ovulation in IR-positive PMOS (Moran et al. 2013).
Macro Template * No single macro ratio is mandated by PMOS guidelines — adherence and energy balance are central (Teede 2023). All templates produce equivalent metabolic outcomes when calories match.
Dietary Preference * Filters Indian meal suggestions. Macro targets are identical — only the food sources change.
Reproductive Goal * Drives safety messaging. Pregnancy: deficit removed, focus on diet quality and GDM screening. Aggressive deficits contraindicated in pregnancy.
PMOS Metabolic Correction EXPERIMENTAL 2025 meta-analysis (Thomas et al., 13 studies): mean REE difference PMOS vs controls = ~30 kcal/day — not physiologically meaningful. No guideline endorses this correction. Enable only if a clinician has confirmed unusually low REE.

Int'l Guidelines 2023 (formerly PCOS) · Mifflin–St Jeor 1990 · Moran et al. 2013 · Thomas et al. 2025 · WHO/FAO PAL Bands

PMOS DIETITIAN SUPPORT

1:1 PMOS Nutrition Coaching

Personalised meal plans, macro targets calibrated to your labs, and Indian low-GI food education from our PMOS-specialist dietitians.

Book Free Consultation →

WHAT THIS CALCULATOR GIVES YOU

Adjusted TDEEMifflin–St Jeor REE × PAL with optional PMOS correction
🥩
IR-Optimised Macros3 evidence-based templates with gram targets per meal
🌾
Indian Low-GI Meal PlanMillets, pulses, whole grains with GI values
💊
Supplement GuidanceInositol, Vitamin D, Omega-3 — evidence summary
🔬
Evidence ReferencesAll outputs linked to PMOS guidelines and trials

CLINICAL REFERENCES

Teede HJ et al. (2026)PMOS name change — The Lancet. DOI:10.1016/S0140-6736(26)00717-8
Teede HJ et al. (2023)Int'l Evidence-Based PCOS Guidelines. Hum Reprod Open 2023(3)
Moran LJ et al. (2013)Diet composition in PCOS. J Acad Nutr Diet 113(4):520–528
Thomas A et al. (2025)REE in PCOS: meta-analysis. medRxiv (13 studies, Bayesian)
Mifflin MD et al. (1990)Predictive REE equation. Am J Clin Nutr 51(2):241–247
Szczuko M et al. (2021)Nutrition and lifestyle in PCOS/PMOS. Nutrients 13(10):3431

This calculator is an educational and clinical-support tool for Polyendocrine Metabolic Ovarian Syndrome (PMOS, formerly PCOS), aligned with International Guidelines (2023) where evidence exists. Many dietary recommendations are based on low-to-moderate quality evidence. This tool does not replace individualised care from a registered dietitian, gynaecologist, or endocrinologist. Women with disordered eating, pregnancy, significant comorbidities, or severe obesity must seek direct clinical supervision before following any energy prescription. PMOS name change: Teede HJ et al., The Lancet, 2026.